Recurrent central giant cell granuloma in the mandible. Nonsurgical treatment methods, such as intralesional corticosteroid injections, systemic calcitonin and interferon have been reported. Central giant cell lesions are benign intraosseous proliferative lesions that have considerable local aggressiveness. Central giant cell granuloma cgcg is a benign intraosseous lesion that occurs in long bones. Giant cell reparative granuloma of the orbit associated. Giant cell reparative granuloma, features of cgcg is its ability to cross the midline of the traumatic bone cyst and fibrous fibrooseous mandible. Central giant cell granuloma is an uncommon benign intraosseus lesion of jaws. Unsurprisingly, ameloblastomas arise from ameloblasts, which are part of the odontogenic epithelium, responsible for enamel production and eventual crown formation. Central giant cell granuloma cgcg is a benign osteolytic lesion of the jaws that is composed of osteoclastlike giant cells arranged in a vascular stroma, which can become aggressive. This is in contrast to the giant cell tumor of long bones, where the giant. The purpose of this study was to determine the ct characteristics and describe possible mr imaging features of gcg of the craniofacial bones. Imaging of giant cell tumor and giant cell reparative. Giant cell granuloma was first identified by jaffe in 1953. Central giant cell granuloma a case report balaji p.
Noonan syndrome associated with central giant cell. Giantcell reparative granuloma of the hand and foot bones ratnerv. Dorfmanhd department of orthopaedic surgery, montefiore medical center, bronx, new york 104672490. Central giant cell lesions granulomas, also known as giant cell reparative cystsgranulomas, occurs. An aggressive central giant cell granuloma in a pediatric. Central giant cell granuloma of the mandible american. The patient is on regular followup for the past one year with no signs of recurrence. Central giant cell granuloma of the jaws and giant cell tumor. Malignancy in giant cell tumor is rare central giant cell granuloma and peripheral giant cell granuloma of the jaw and oral cavity are identical in histopathologic features, although they are different in pathogenesis and clinical behavior. The referring doctor had suggested a diagnosis of eruption. The traditional treatment of cgcg of the jaws has been surgical. Combination therapies for the treatment of recurrent central.
Pdf central giant cell granuloma is an uncommon, benign, and proliferative lesion whose. A case of a 36yearold male with a central giant cell. Central giant cell granuloma appears references as poorly defined unilocular radiolucency or multilocular radiolucency with scalloped borders. Central giant cell granuloma cgcg of the jaw is a benign osteolytic lesion. Sep 01, 2001 the radiologic features of giant cell tumor gct and giant cell reparative granuloma gcrg of bone often strongly suggest the diagnosis and reflect their pathologic appearance. The central giant cell granuloma is often found in the mandible commonly occurring in patients under. Aggressive central giant cell granuloma occurring as peripheral one is a very rare case and the treatment of aggressive central giant cell granuloma with curettage has shown a high recurrence rate within a.
It is twice as common in females and is more likely to occur before age 30. A histological comparison of the giant cells in the central giant cell granuloma of the jaws and the giant cell tumor of long bone. Ct and mr imaging of giant cell granuloma of the craniofacial. Jul 20, 20 central giant cell granuloma cgcg is a relatively uncommon benign bony lesion of a variably aggressive nature, accounting for less than 7% of all benign jaw lesions. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Aug 22, 2012 central giant cell lesions are benign intraosseous proliferative lesions that have considerable local aggressiveness. Peripheral giant cell granuloma is, for all practical purposes, a sitespecific variant of pyogenic granuloma embedded with osteoclastlike multinucleated giant cells and arising exclusively from the periodontal ligament enclosing the root of a tooth. Intralesional corticosteroid injection for central giant. After surgical excision, histological examination of the surgical specimen concluded a. The clinical presentation of cgcg ranges from a slow and asymptomatic growth detected on routine radiographs to more aggressive lesions characterized by. The diagnosis and management of giant cell lesions of the jaws. A granuloma is a focal compact collection of inflammatory cells, mononuclear cells predominating, usually as a result of the persistence of a nondegradable product and of active cell mediated hypersensitivity.
Langerhans cell histiocytosis is a group of disorders characterized for a clonal proliferation of langerhans cells 2, 6, with a wide spectrum of clinical presentations, including solitary bone lesions with excellent prognosis, known as eosinophilic granuloma, and other systemic presentations with a multiorganic, disseminated and progressive course, previously known as handschuller. At radiography, gct often demonstrates a metaepiphyseal location with extension to subchondral bone. Central giant cell granuloma cgcg is a benign aggressive destructive osteolytic lesion of osteoclastic origin. Central giantcell granuloma cgcg is a localised benign condition of the jaws. Giant cell granuloma occurs either as a peripheral exophytic lesion on the gingiva or as a centrally located lesion within the jaw, skull, or facial bones. For the previously reported cases in one female and three males, the. The central giant cell granuloma cgcg is considered a benign, nonneoplastic lesion of bone found in a younger age group who are usually less than 30 years of age. Although there is not enough evidence that this lesion promotes reparative process, it was denominated reparative giant cell granuloma.
Spontaneous remission of eosinophilic granuloma of the. Sep 11, 2017 symptoms of langerhans cell histiocytosis lch can vary greatly from person to person depending on how much of the body is involved and what parts are affected. Central giant cell granuloma cgcg is a benign intraosseous lesion of the jaws that is found predominantly in children and young adults. Preserving of a tooth related with central giant cell. It is an uncommon tumor in jaws, its etiology and pathogenesis is unknown. Langerhans cell histiocytosis genetic and rare diseases.
Mr imaging depicted a right temporal expansile multiloculated lesion, with hyper and hypointense signal areas on t2weighted images, heterogeneously enhancing after gadolinium administration. Not the same tumor as giant cell lesion of the small bones. Central giant cell tumors typically demonstrate a peak incidence in the. Some investigators have suggested that peripheral giant cell. The purpose of this case report is to report the diagnosis and the treatment of a recurrent central giant cell lesion in the maxilla. The lesion principally affects the mandible and maxilla. Granulomatous disorders comprise a large family sharing the histological denominator of granuloma formation. Histologically identical to central giant cell granuloma. Giant cell reparative granuloma of the orbit associated with cherubism ramon l. This peripheral giant cell granuloma involved the maxillary gingiva associated with an erupting central incisor of a 6yearold girl. Although benign, it is a locally aggressive neoplasm with a high rate of recurrence. Also called giant cell reparative granuloma central if intraosseous. Central giant cell lesions granuloma dr yuranga weerakkody and assoc prof frank gaillard et al.
Central giant cell granuloma cgcg is a benign intraosseous lesion. It may exhibit aggressive biologic behavior, characterized by localized swelling, pain, rapid growth, bony expansion, cortical. Central giant cell lesions the central giant cell granuloma, also known as cgcl or giant cell lesion, was first described by jaffe in 1953. The clinical presentation of cgcg ranges from a slow and asymptomatic growth detected on routine radiographs to more aggressive lesions characterized by painful symptoms and rapid and. Cgcg is generally found more frequently in females than in males, with a ratio of 2. Central giant cell lesion is a nonneoplastic proliferation, usually asymptomatic, of unknown etiology. Diagnosis, treatment, and outcome of giantcell myocarditis. Central giant cell granuloma cgcg is an uncommon, benign, and. Jun 19, 2018 peripheral giant cell granuloma has an excellent prognosis.
This lesion occurs most commonly in maxilla and mandible, rare cases have been reported in the bones of skull, including the orbit 3,4, paranasal sinuses, cranial vault, temporal 7,8, sphenoid and occipital bones. The etiology, pathogenesis, histopathologic diagnosis, prognosis, and treatment of giant cell reparative granulomas of the skull are controversial. Case report giant cell tumor of the maxilla in an 8 year. Divided into non and aggressive subtypes, the aggressive subtype is relatively rare and can occasionally progress rapidly, resulting in significant morbidity.
An aggressive central giant cell granuloma in a pediatric patient. Giant cell myocarditis often escapes diagnosis until autopsy or transplantation and has defied proper treatment trials for its rarity and deadly behavior. Approximately 20% of cases are associated with dentigerous cysts and unerupted teeth. Central giant cell granulomas of the condyle are rare. A clinicopathological classification of granulomatous. Central giant cell granuloma cgcg of the jaws is a benign, intraosseous, osteolytic lesion of debatable etiology.
Surgical treatment and reconstruction for central giant cell. True giant cell neoplasms, such as the giant cell tumor that occurs in the humerus and femur, rarely occur in. Mr imaging depicted a right temporal expansile multiloculated lesion, with hyper and hypointense signal. Thought to represent a reparative response to intrabony haemorrhage and. This is in contrast to the giant cell tumor of long bones, where.
The condition was first identified in 1953 by jaffe, who initially termed this lesion as a central giant cell reparative granuloma. This report describes a case of an aggressive variety of cgcg which was augmented following. Frontal giant cell reparative granuloma invading orbit. It was first described by jaffe as central giant cell reparative granuloma. A 31yearold brazilian woman presented to our surgery service for evaluation of a cystic lesion in her teeth and 15, although she had previously received. Peripheral giantcell granuloma an overview sciencedirect. A reactive response to trauma is the most accepted etiopathogenesis of cgcg. Thought to represent a reparative response to intrabony haemorrhage and inflammation, cgcg was once regarded as a reactive lesion. Aggressive central giant cell granuloma mimicking peripheral. Treatment of central giant cell lesions using bisphosphonates. It is actually an asymptomatic lesion which becomes evident during routine radiographic examination or as a result of painless but visible expansion of. The true nature of this lesion is controversial and remains unknown. We present a case of an aggressive central giant cell granuloma cgcg in a six yearold female.
Aggressive variant of central giant cell granuloma austin. Introduction giant cell reparative granuloma was first described by jaffe in 1953. Nonsurgical treatments with alpha interferon aifn, calcitonin. Benign but locally aggressive primary bone neoplasm composed of mononuclear round to spindle cells with numerous evenly dispersed osteoclastlike giant cells. Cgcg lacks in clinical and radiographical pathognomonic features to distinguish from. These two different groups of pathological entities of giant cell. Central giant cell granuloma of the jaws regress with calcitonin therapy. There is a complex interplay between invading organism or prolonged. We report a 14yearold girl with an advanced recurrent giant cell reparative granuloma of the skull base and paranasal sinuses whose only clinical manifestation was a loss of vision. Central giant cell granuloma of the jaws and giant cell.
Intralesional corticosteroid injection for central giant cell. Intralesional steroid treatment of central giant cell. Clinical and radiographic features are not definitive diagnosis in cgcg. Peripheral giant cell granuloma has an excellent prognosis. We report a case of noonan syndrome associated with central giant cell granuloma. Central giant cell tumor cgct, often denominated as central giant cell granuloma cgcg or giant cell lesion gcl, is a rare benign condition with unpredictable variable biologic behavior most frequently occurring in the mandible andor maxilla. Central giant cell granuloma cgcg has unpredictable biologic behavior, nonspecific radiographic features and is amenable to a plethora of treatment alternatives. Some investigators have suggested that peripheral giant cell granulomas that develop in association with dental implants seem to have a higher risk. Jaffe hl 1953 giant cell reparative granuloma, traumatic bone cyst and.
Immunohistochemical expression of p53, mdm2, ki67 and pcna in central giant cell granuloma and giant cell tumor. Aggressive central giant cell granuloma occurring as peripheral one is a very rare case and the treatment of aggressive central giant cell granuloma with curettage has shown a high recurrence rate within a span of six months, but in our case even after one year followup, no recurrence of the lesion was noticed. Peripheral giant cell granuloma pgcg and central giant cell granuloma 6, 7,8,9. Surgically treated central giant cell granuloma in sixyearold. Central giant cell granuloma cgcg is a relatively uncommon benign bony lesion of a variably aggressive nature. Central giant cell granulomas are benign tumours of the mandible, presenting in children and young adults. Prompt diagnosis and management can greatly improve longterm outcomes. The disease can affect virtually every organ, including skin, bones, lymph nodes, bone marrow, liver, spleen, lungs, gastrointestinal tract, thymus, central nervous system, and hormone glands. Intralesional corticosteroid injection for central giant cell granuloma.
A recurrence rate of 1020% has been reported in most series. Diagnosis of central giant cell granuloma is normally made histologically from an incisional biopsy. Central giant cell granuloma of the mandibular condyle. Giant cell tumour central giant cell lesion of the maxilla. Traditional treatment has been local curettage, although aggressive subtypes. Current therapy rests on multipledrug immunosuppression but its prognostic influence remains poorly known.
Central giant cell granuloma cgcg is a benign intraosseous lesion of the. The central giant cell granuloma cgcg is an uncommon benign bony lesion that accounts for less than 7% of all benign lesions of the jaws in toothbearing areas. Recently, bisphosphonates have been used to treat central giant cell lesions. Central giant cell granuloma cgcg is a rare, nonneoplastic, benign lesion that exhibits expansive and osteolytic biological behavior. We report a case of large temporal giant cell reparative granuloma in a 72yearold man. Central giant cell granuloma cgcg is a relatively uncommon benign bony lesion of a variably aggressive nature, accounting for less than 7% of all benign jaw lesions. A 31yearold brazilian woman presented to our surgery service for evaluation. Although there is not enough evidence that this lesion promotes reparative process, it was denominated reparative giant cell granuloma 2, 2530. The first type is nonaggressive, slow growing, does not show root resorption or cortical perforation, and often shows new bone formation. Central giant cell granuloma formerly called as giant cell reparative granuloma is a non neoplastic proliferative lesion of unknown etiology. Central giant cell granulomas are more common in the anterior mandible, often crossing the midline and causing painless swellings. The aim of present study was to compare cd 68 and factor viii related antigen. The central giant cell granuloma, also known as cgcl or giant cell lesion, was first described by jaffe in 1953. Central giant cell granuloma was 1st described in jaws by jaffe 1953.
Giant cell granuloma gcg is an uncommon, benign, proliferative, intraosseous lesion representing giant cell tumour central giant cell lesion of the maxilla. Clinically and radiologically, a differentiation between aggressive and nonaggressive lesions can be made. The appearance is generally distinctive with multinucleated giant cells spread throughout the lesion but often focal in distribution around areas of possible hemorrhage figure 4. Owing to its reparative character, it was called reparative central giant cell granuloma. Central giant cell granuloma cgcg of the jaws and giant cell tumor gct of bone share a number of similarities and dissimilarities in respect of their histopathological, cytometric and. A case of a 36yearold male with a central giant cell lesion. Pdf on jun 7, 2019, nilotpol kashyap and others published central. Recurrent giant cell reparative granuloma of the skull base. Surgical treatment has been the traditional accepted modality reducing chances of recurrence. Unusual aggressive behavior of central giant cell granuloma.
1176 158 1489 232 656 1127 101 167 920 1021 397 1201 1050 525 174 939 946 1518 64 37 1298 821 1088 1165 84 841 1097 242 835